Treatment Patterns and Outcomes in Botulinum Therapy for Patients with Facial Synkinesis

JAMA Facial Plastic Surgery

Volumn 21, Issue 3, 2019, Pages 244-251

  Shinn, Justin R ^a   Nwabueze, Nkechi N ^b   Du, Liping ^c   Patel, Priyesh N ^a   Motamedi, Kevin K ^d   Norton, Cathey ^e   Ries, William R ^a   Stephan, Scott J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d KAISER PERMANENTE   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; FACE MUSCLE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SYNKINESIS; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXINS, TYPE A; FACIAL MUSCLES; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; SYNKINESIS; TREATMENT OUTCOME;

EID: 85061012870     PISSN: 21686076     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamafacial.2018.1962     Document Type: Article

References (39)

1. Guerrissi JO. Selective myectomy for postparetic facial synkinesis. Plast Reconstr Surg. 1991; 87 (3): 459-466. doi: 10.1097/00006534-199103000-00010 1998016
2. Salles AG, da Costa EF, Ferreira MC, Remigio AF, Moraes LB, Gemperli R. Epidemiologic overview of synkinesis in 353 patients with longstanding facial paralysis under treatment with botulinum toxin for 11 years. Plast Reconstr Surg. 2015; 136 (6): 1289-1298. doi: 10.1097/PRS.0000000000001802 26595022
3. Monini S, De Carlo A, Biagini M, Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol. 2011; 131 (8): 882-886. doi: 10.3109/00016489.2011.577447 21534714
4. Dalla Toffola E, Bossi D, Buonocore M, Montomoli C, Petrucci L, Alfonsi E. Usefulness of BFB/EMG in facial palsy rehabilitation. Disabil Rehabil. 2005; 27 (14): 809-815. doi: 10.1080/09638280400018650 16096233
5. Choi KH, Rho SH, Lee JM, Jeon JH, Park SY, Kim J. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis. J Plast Reconstr Aesthet Surg. 2013; 66 (8): 1058-1063. doi: 10.1016/j.bjps.2013.04.012 23683725
6. Filipo R, Spahiu I, Covelli E, Nicastri M, Bertoli GA. Botulinum toxin in the treatment of facial synkinesis and hyperkinesis. Laryngoscope. 2012; 122 (2): 266-270. doi: 10.1002/lary.22404 22252570
7. Fu L, Bundy C, Sadiq SA. Psychological distress in people with disfigurement from facial palsy. Eye (Lond). 2011; 25 (10): 1322-1326. doi: 10.1038/eye.2011.158 21720412
8. Rogers CR, Schmidt KL, VanSwearingen JM, Automated facial image analysis: detecting improvement in abnormal facial movement after treatment with botulinum toxin A. Ann Plast Surg. 2007; 58 (1): 39-47. doi: 10.1097/01.sap.0000250761.26824.4f 17197940
9. Cabin JA, Massry GG, Azizzadeh B. Botulinum toxin in the management of facial paralysis. Curr Opin Otolaryngol Head Neck Surg. 2015; 23 (4): 272-280. doi: 10.1097/MOO.0000000000000176 26101876
10. Borodic G, Bartley M, Slattery W, Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plast Reconstr Surg. 2005; 116 (1): 36-43. doi: 10.1097/01.PRS.0000169689.27829.C4 15988245
11. Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg. 2008; 24 (2): 242-249. doi: 10.1055/s-2008-1075840 18470836
12. Mehdizadeh OB, Diels J, White WM. Botulinum toxin in the treatment of facial paralysis. Facial Plast Surg Clin North Am. 2016; 24 (1): 11-20. doi: 10.1016/j.fsc.2015.09.008 26611697
13. Novak CB. Rehabilitation strategies for facial nerve injuries. Semin Plast Surg. 2004; 18 (1): 47-52. doi: 10.1055/s-2004-823123 20574470
14. Jowett N, Hadlock TA. An evidence-based approach to facial reanimation. Facial Plast Surg Clin North Am. 2015; 23 (3): 313-334. doi: 10.1016/j.fsc.2015.04.005 26208770
15. Terzis JK, Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in adult patients. Plast Reconstr Surg. 2012; 129 (6): 925e-939e. doi: 10.1097/PRS.0b013e318230e758 22634691
16. McElhinny ER, Reich I, Burt B, Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A. Ophthalmic Plast Reconstr Surg. 2013; 29 (3): 175-178. doi: 10.1097/IOP.0b013e3182873d7d 23467287
17. Mandrini S, Comelli M, Dall'angelo A, Long-term facial improvement after repeated BoNT-A injections and mirror biofeedback exercises for chronic facial synkinesis: a case-series study. Eur J Phys Rehabil Med. 2016; 52 (6): 810-818. 27164539
18. Azuma T, Nakamura K, Takahashi M, Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis. Otolaryngol Head Neck Surg. 2012; 146 (1): 40-45. doi: 10.1177/0194599811424125 21965443
19. Couch SM, Chundury RV, Holds JB. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthalmic Plast Reconstr Surg. 2014; 30 (3): 246-250. doi: 10.1097/IOP.0000000000000086 24807539
20. Chua CN, Quhill F, Jones E, Voon LW, Ahad M, Rowson N. Treatment of aberrant facial nerve regeneration with botulinum toxin A. Orbit. 2004; 23 (4): 213-218. doi: 10.1080/01676830490512233 15590522
21. Borodic GE, Pearce LB, Cheney M, Botulinum A toxin for treatment of aberrant facial nerve regeneration. Plast Reconstr Surg. 1993; 91 (6): 1042-1045. doi: 10.1097/00006534-199305000-00011 8479969
22. Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010; 32 (17): 1414-1418. doi: 10.3109/09638280903514697 20156046
23. Maria CM, Kim J. Individualized management of facial synkinesis based on facial function. Acta Otolaryngol. 2017; 137 (9): 1010-1015. doi: 10.1080/00016489.2017.1316871 28471705
24. Lee JM, Choi KH, Lim BW, Kim MW, Kim J. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis. J Plast Reconstr Aesthet Surg. 2015; 68 (1): 71-78. doi: 10.1016/j.bjps.2014.08.067 25444667
25. Cronin GW, Steenerson RL. The effectiveness of neuromuscular facial retraining combined with electromyography in facial paralysis rehabilitation. Otolaryngol Head Neck Surg. 2003; 128 (4): 534-538. doi: 10.1016/S0194-5998(03)00005-6 12707657
26. Mehta RP, WernickRobinson M, Hadlock TA. Validation of the Synkinesis Assessment Questionnaire. Laryngoscope. 2007; 117 (5): 923-926. doi: 10.1097/MLG.0b013e3180412460 17473697
27. Kleiss IJ, Beurskens CH, Stalmeier PF, Ingels KJ, Marres HA. Synkinesis assessment in facial palsy: validation of the Dutch Synkinesis Assessment Questionnaire. Acta Neurol Belg. 2016; 116 (2): 171-178. doi: 10.1007/s13760-015-0528-7 26377698
28. Patel PN, Owen SR, Norton CP, Outcomes of buccinator treatment with botulinum toxin in facial synkinesis. JAMA Facial Plast Surg. 2018; 20 (3): 196-201. doi: 10.1001/jamafacial.2017.1385 28973100
29. Wei LA, Diels J, Lucarelli MJ. Treating buccinator with botulinum toxin in patients with facial synkinesis: a previously overlooked target. Ophthalmic Plast Reconstr Surg. 2016; 32 (2): 138-141. doi: 10.1097/IOP.0000000000000449 26325382
30. Risoud M, Aljudaibi N, Duquennoy-Martinot V, Guerreschi P. Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: repartition and kinetics of doses used. Ann Chir Plast Esthet. 2016; 61 (1): 10-15. doi: 10.1016/j.anplas.2015.04.002 25953657
31. Chundury RV, Perry JD. Re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target". Ophthalmic Plast Reconstr Surg. 2016; 32 (1): 70. doi: 10.1097/IOP.0000000000000608 26735958
32. Armstrong MW, Mountain RE, Murray JA. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci. 1996; 21 (1): 15-20. doi: 10.1111/j.1365-2273.1996.tb01018.x 8674216
33. Ito H, Ito H, Nakano S, Kusaka H. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation. Acta Neurol Scand. 2007; 115 (4): 271-274. doi: 10.1111/j.1600-0404.2006.00746.x 17376126
34. On AY, Yaltirik HP, Kirazli Y. Agreement between clinical and electromyographic assessments during the course of peripheric facial paralysis. Clin Rehabil. 2007; 21 (4): 344-350. doi: 10.1177/0269215507073177 17613575
35. Moran CJ, Neely JG. Patterns of facial nerve synkinesis. Laryngoscope. 1996; 106 (12, pt 1): 1491-1496. doi: 10.1097/00005537-199612000-00009 8948609
36. Beurskens CH, Oosterhof J, Nijhuis-van der Sanden MW. Frequency and location of synkineses in patients with peripheral facial nerve paresis. Otol Neurotol. 2010; 31 (4): 671-675. 20351606
37. Dall'Angelo A, Mandrini S, Sala V, Platysma synkinesis in facial palsy and botulinum toxin type A. Laryngoscope. 2014; 124 (11): 2513-2517. doi: 10.1002/lary.24732 24764160
38. Cai ZG, Shi XJ, Lu XG, Yang ZH, Yu GY. Efficacy of functional training of the facial muscles for treatment of incomplete peripheral facial nerve injury. Chin J Dent Res. 2010; 13 (1): 37-43. 20936190
39. Nakamura K, Toda N, Sakamaki K, Kashima K, Takeda N. Biofeedback rehabilitation for prevention of synkinesis after facial palsy. Otolaryngol Head Neck Surg. 2003; 128 (4): 539-543. doi: 10.1016/S0194-5998(02)23254-4 12707658